453 related articles for article (PubMed ID: 27925182)
41. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
42. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
[TBL] [Abstract][Full Text] [Related]
43. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
44. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
45. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
Yu MH; Luo Y; Qin SL; Zhong M
Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
[TBL] [Abstract][Full Text] [Related]
47. High Ran level is correlated with poor prognosis in patients with colorectal cancer.
Fan H; Lu Y; Qin H; Zhou Y; Gu Y; Zhou J; Wang X; Fan D
Int J Clin Oncol; 2013 Oct; 18(5):856-63. PubMed ID: 22956174
[TBL] [Abstract][Full Text] [Related]
48. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
Makino M; Yamane N; Taniguchi T; Honboh T; Kurayoshi K; Kaibara N
Anticancer Res; 2000; 20(3B):2055-9. PubMed ID: 10928151
[TBL] [Abstract][Full Text] [Related]
49. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
[TBL] [Abstract][Full Text] [Related]
50. Prognostic role of nucleophosmin in colorectal carcinomas.
Yang YF; Zhang XY; Yang M; He ZH; Peng NF; Xie SR; Xie YF
Asian Pac J Cancer Prev; 2014; 15(5):2021-6. PubMed ID: 24716928
[TBL] [Abstract][Full Text] [Related]
51. Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
Chen Y; Xie Y; Xu L; Zhan S; Xiao Y; Gao Y; Wu B; Ge W
Int J Cancer; 2017 Feb; 140(4):900-913. PubMed ID: 27813080
[TBL] [Abstract][Full Text] [Related]
52. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.
Wang Y; Wei J; Zhang S; Li G; Zhang T; Yu X; Chen H; Liu M
Tumour Biol; 2015 Nov; 36(11):8781-7. PubMed ID: 26055144
[TBL] [Abstract][Full Text] [Related]
54. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y
J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of stromal GREM1 expression in colorectal cancer.
Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
[TBL] [Abstract][Full Text] [Related]
56. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
[TBL] [Abstract][Full Text] [Related]
57. High SHIP2 expression indicates poor survival in colorectal cancer.
Yang J; Fu M; Ding Y; Weng Y; Fan W; Pu X; Ge Z; Zhan F; Ni H; Zhang W; Jin F; Xu N; Li J; Qiu L; Wang J; Gu X
Dis Markers; 2014; 2014():218968. PubMed ID: 25525286
[TBL] [Abstract][Full Text] [Related]
58. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
59. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
